📗 Cite This Artifact
vasopressin-v1a-neurons
Vasopressin V1a Receptor Neurons
Introduction
Vasopressin V1A Receptor [Neurons](/entities/neurons) is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Vasopressin V1a receptor-expressing neurons constitute a fundamental component of the neuropeptidergic systems governing social behavior, stress responses, fluid homeostasis, and circadian rhythms. The arginine vasopressin (AVP) system, acting primarily through V1a receptors (AVPR1A) in the central nervous system, modulates complex behaviors and physiological processes that are disrupted in neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and related disorders. This comprehensive page explores the molecular biology, neuroanatomy, behavioral functions, and disease relevance of V1a receptor neurons, with particular emphasis on their emerging roles in neurodegeneration and therapeutic potential. [@albers2022]
Molecular Biology of the V1a Receptor
Gene Structure and Expression
The AVPR1A gene encodes the arginine vasopressin receptor 1A, a G protein-coupled receptor belonging to the vasopressin/oxytocin receptor family. Located on chromosome 12q14.2 in humans, AVPR1A spans approximately 19 kilobases and contains multiple exons. [@ebner2021]
Vasopressin V1a Receptor Neurons
Introduction
Vasopressin V1A Receptor [Neurons](/entities/neurons) is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Vasopressin V1a receptor-expressing neurons constitute a fundamental component of the neuropeptidergic systems governing social behavior, stress responses, fluid homeostasis, and circadian rhythms. The arginine vasopressin (AVP) system, acting primarily through V1a receptors (AVPR1A) in the central nervous system, modulates complex behaviors and physiological processes that are disrupted in neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and related disorders. This comprehensive page explores the molecular biology, neuroanatomy, behavioral functions, and disease relevance of V1a receptor neurons, with particular emphasis on their emerging roles in neurodegeneration and therapeutic potential. [@albers2022]
Molecular Biology of the V1a Receptor
Gene Structure and Expression
The AVPR1A gene encodes the arginine vasopressin receptor 1A, a G protein-coupled receptor belonging to the vasopressin/oxytocin receptor family. Located on chromosome 12q14.2 in humans, AVPR1A spans approximately 19 kilobases and contains multiple exons. [@ebner2021]
Transcriptional Regulation: [@raggenbass2019]
- Promoter Elements: The AVPR1A promoter contains cyclic AMP response elements (CREs) and steroid hormone response elements, enabling hormonal modulation of receptor expression.
- Alternative Splicing: Multiple AVPR1A transcript variants have been identified, potentially generating isoforms with distinct signaling properties and tissue distributions.
- Epigenetic Regulation: [DNA methylation](/entities/dna-methylation) and [histone modifications](/entities/histone-modifications) regulate AVPR1A expression in a cell-type-specific manner.
Protein Structure and Signaling
AVPR1A is a 418-amino acid GPCR with classic seven-transmembrane domain architecture: [@stoop2022]
Structural Features: [@lim2020]
- Extracellular Domain: Ligand-binding pocket formed by transmembrane domains 3, 5, 6, and 7
- Intracellular Domains: G protein coupling motifs in intracellular loops 2 and 3
- Post-translational Modifications: N-glycosylation sites in the N-terminus, palmitoylation in the C-terminal tail
- Gq/11 Coupling: Primary signaling through Gq proteins, activating phospholipase C (PLC)
- PLC Pathway: Generates IP3 and DAG, leading to intracellular calcium mobilization and PKC activation
- MAPK Activation: V1a receptor stimulation activates ERK1/2 MAPK pathways
- β-Arrestin Recruitment: Enables receptor internalization and G protein-independent signaling
Ligand Specificity
Arginine vasopressin (AVP) is the primary endogenous ligand for V1a receptors: [@kaler2022]
AVP Structure: A 9-amino acid peptide (CYFQNCPRG) with a disulfide bridge between cysteine residues, synthesized as a preprohormone in hypothalamic neurons. [@caldwell2018]
Binding Affinities: [@bielsky2021]
- AVPR1A: High affinity for AVP (Kd ~0.5-2 nM)
- Lower affinity for oxytocin (approximately 10-fold lower than AVP)
- Synthetic ligands (e.g., V1a-selective agonists and antagonists) enable targeted manipulation
Neuroanatomical Distribution
Central Nervous System Expression
V1a receptor expression in the brain is extensive and region-specific:
Hypothalamus:
- Supraoptic Nucleus (SON): Contains vasopressinergic magnocellular neurons; V1a autoreceptors modulate AVP release
- Paraventricular Nucleus (PVN): V1a expression in both parvocellular and magnocellular divisions; regulates stress responses and autonomic function
- Suprachiasmatic Nucleus (SCN): V1a receptors mediate AVP effects on circadian rhythms
- Amygdala: High V1a expression in the central nucleus (CeA) and bed nucleus of the stria terminalis (BNST); critical for fear, anxiety, and social behaviors
- [Hippocampus](/brain-regions/hippocampus): CA1 pyramidal cells and dentate gyrus granule cells express V1a; modulates synaptic plasticity and memory
- Septum: Lateral septum shows dense V1a receptor binding; regulates social recognition and anxiety
- Prefrontal Cortex: V1a modulates executive function and decision-making
- [Entorhinal Cortex](/brain-regions/entorhinal-cortex): V1a influences spatial memory processing
- Piriform Cortex: Olfactory processing may involve V1a signaling
- Locus Coeruleus: V1a modulation of norepinephrine neurons affects arousal and stress responses
- Dorsal Raphe Nucleus: Interactions with serotonin systems influence mood and social behavior
- Nucleus of the Solitary Tract: V1a contributes to autonomic reflex regulation
Peripheral Expression
V1a receptors are also expressed in peripheral tissues:
- Vascular Smooth Muscle: Mediates vasoconstriction
- Liver: Modulates glycogenolysis and gluconeogenesis
- Kidney: Influences renal blood flow
- Adrenal Gland: Modulates corticosteroid secretion
- Platelets: AVP affects platelet aggregation
Physiological Functions
Social Behavior
V1a receptor signaling is fundamental to complex social behaviors:
Pair Bonding:
- V1a receptors in the ventral pallidum and nucleus accumbens are critical for partner preference formation
- Prairie voles with V1a knockdown fail to form pair bonds
- Vasopressin microinfusion into the ventral pallidum induces partner preference
- V1a activity in the hippocampus is essential for social memory formation
- V1a antagonists impair social recognition
- V1a receptor density in the lateral septum correlates with social novelty seeking
- V1a modulates vocalization patterns in various species
- In mice, V1a influences ultrasonic vocalizations during social interactions
- Non-human primates show V1a-dependent changes in social grooming behavior
Stress Response
V1a receptors modulate hypothalamic-pituitary-adrenal (HPA) axis function:
Acute Stress:
- V1a activation enhances ACTH release from the pituitary
- V1a receptors in the PVN regulate CRH neuron activity
- V1a antagonists blunt stress-induced corticosterone release
- V1a expression is altered by chronic stress exposure
- V1a dysfunction may contribute to stress-related disorders
- Interactions between V1a and glucocorticoid receptors influence stress resilience
- V1a modulates anxiety-like behaviors in conflict tests
- V1a activity in the amygdala affects fear conditioning
- V1a antagonists have anxiolytic-like effects in some paradigms
Fluid Balance and Cardiovascular Regulation
V1a receptors coordinate fluid homeostasis:
Osmoregulation:
- SON and PVN AVP neurons sense plasma osmolality
- V1a receptors mediate AVP's antidiuretic effects on water reabsorption
- V1a in the subfornical organ and organum vasculosum of the lamina terminalis regulate thirst
- V1a-mediated vasoconstriction contributes to blood pressure maintenance
- V1a antagonists lower blood pressure in hypertension models
- Central V1a receptors may influence baroreflex sensitivity
Circadian Rhythms
V1a receptors play essential roles in circadian timekeeping:
Suprachiasmatic Nucleus Function:
- AVP is a major SCN neuropeptide with circadian secretion patterns
- V1a receptors in the SCN mediate AVP's effects on circadian rhythms
- V1a antagonism alters circadian period and phase shifting
- V1a modulates daily activity patterns
- V1a influences sleep-wake cycling
- Disrupted V1a signaling may contribute to circadian disturbances in neurodegeneration
Memory and Learning
V1a receptor signaling modulates cognitive processes:
Spatial Memory:
- V1a activity in the hippocampus is required for spatial memory consolidation
- V1a antagonists impair performance in Morris water maze
- V1a agonists enhance memory consolidation in some paradigms
- V1a in the lateral septum is essential for social recognition memory
- V1a knockdown impairs social novelty detection
- V1a receptor polymorphisms are associated with social memory deficits
- Prefrontal cortex V1a influences working memory processes
- V1a modulation of dopaminergic signaling affects working memory
- Age-related V1A changes may contribute to cognitive decline
Role in Neurodegenerative Diseases
Alzheimer's Disease
V1a receptor dysfunction has several implications for Alzheimer's disease:
Memory Impairment:
- V1a signaling modulates hippocampal synaptic plasticity, which is disrupted in AD
- AVP and V1a activity influence memory consolidation processes
- V1a receptor density is reduced in AD brain tissue
- V1a agonists have shown memory-enhancing effects in AD models
- Social behavior deficits in AD may involve V1a system dysfunction
- The bed nucleus of the stria terminalis, rich in V1a receptors, shows early [tau](/proteins/tau) pathology
- Loss of V1a-mediated social recognition may contribute to personality changes
- AD patients commonly exhibit circadian rhythm disruptions
- V1a in the SCN may contribute to these disturbances
- V1a dysfunction could exacerbate sleep-wake cycle fragmentation
- V1a agonists may improve memory and social function in AD
- V1a modulation could address circadian disturbances
- Combined V1a and cholinergic approaches warrant investigation
Parkinson's Disease
V1a receptors have several connections to Parkinson's disease:
Autonomic Dysfunction:
- Multiple system atrophy (MSA), often misdiagnosed as PD, involves autonomic failure
- V1a in the nucleus of the solitary tract regulates autonomic reflexes
- V1a dysfunction may contribute to orthostatic hypotension in parkinsonian disorders
- Depression and apathy are common non-motor symptoms in PD
- V1a signaling interacts with dopaminergic systems in reward circuits
- V1a modulation may affect motivational states in PD
- REM sleep behavior disorder (RBD) often precedes PD diagnosis
- V1a in brainstem regulatory centers may influence RBD
- V1a antagonists could potentially improve sleep architecture
Other Neurodegenerative Disorders
Huntington's Disease:
- V1a expression is altered in HD models and human tissue
- Social behavior deficits in HD may involve V1a dysfunction
- V1a modulation could address some HD neuropsychiatric symptoms
- V1a in the frontal cortex and amygdala may contribute to social behavior changes
- Disinhibition and social conduct problems in FTD may involve V1a pathways
- V1a-targeted approaches could complement behavioral interventions
- V1a in autonomic nuclei may contribute to autonomic failure
- V1a agonists could potentially improve blood pressure regulation
- The role of V1a in MSA pathophysiology warrants further investigation
Clinical and Therapeutic Implications
Therapeutic Targets
V1a receptors represent therapeutic targets for multiple conditions:
Memory Enhancement:
- V1a agonists (e.g., selegiline, AVP analogs) have shown cognitive effects
- Selective V1a agonists may improve memory consolidation
- Applications in AD, age-related cognitive decline, and traumatic brain injury
- V1a modulation may improve social functioning in autism spectrum conditions
- Potential for Prader-Willi syndrome, characterized by hyperphagia and social deficits
- V1a gene therapy approaches have been explored in animal models
- V1a antagonists have anxiolytic potential
- Applications in generalized anxiety disorder and PTSD
- V1a-selective compounds may avoid sedation associated with benzodiazepines
- V1a antagonists treat hyponatremia in syndrome of inappropriate ADH secretion (SIADH)
- Potential applications in heart failure and cirrhosis
- Central V1a modulation may complement peripheral approaches
Biomarker Potential
V1a system measures may serve as biomarkers:
- CSF AVP Levels: Altered in AD, PD, and depression
- AVPR1A Polymorphisms: Associated with neuropsychiatric phenotypes
- Peripheral Receptor Expression: May reflect CNS changes
- Neuroimaging: AVPR1A PET ligands under development
Challenges in Drug Development
V1a-targeted therapeutics face several challenges:
- Peripheral vs. Central Effects: Achieving central selectivity is challenging
- Species Differences: V1a receptor pharmacology differs between species
- Signal Diversion: Multiple downstream pathways complicate optimization
- Chronic Effects: Long-term treatment may lead to receptor desensitization
Research Methods
Molecular Approaches
- In Situ Hybridization: Localizes AVPR1A mRNA in brain tissue
- Immunohistochemistry: Maps receptor protein distribution
- Cell-type-specific RNA-seq: Characterizes V1a neuron transcriptomes
Electrophysiology
- Patch-clamp Recording: Studies V1a effects on neuronal excitability
- Calcium Imaging: Visualizes V1a-mediated signaling in real time
Behavioral Analysis
- Social Behavior Tests: Partner preference, social recognition, social investigation
- Memory Tests: Morris water maze, object recognition, social memory
- Stress Paradigms: Elevated plus maze, forced swim test
Genetic Models
- Knockout Mice: AVPR1A knockout mice show social and memory deficits
- Transgenic overexpression: AVPR1A overexpression alters social behavior
- Human genetics: AVPR1A polymorphisms associate with social behavior traits
See Also
- [Vasopressin Peptide](/peptides/vasopressin)
- [Vasopressin Receptor Signaling Pathway](/mechanisms/vasopressin-signaling)
- [Hypothalamic Neurons](/cell-types/hypothalamic-neurons)
- [Paraventricular Nucleus Neurons](/cell-types/paraventricular-nucleus)
- [Supraoptic Nucleus Neurons](/cell-types/supraoptic-nucleus)
- [Amygdala Neurons](/cell-types/amygdala-neurons)
- [Hippocampal CA1 Neurons](/cell-types/hippocampal-ca1-neurons)
- [Lateral Septum Neurons](/cell-types/lateral-septum-neurons)
- [Suprachiasmatic Nucleus Neurons](/cell-types/suprachiasmatic-nucleus)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Social Behavior in Neurodegeneration](/mechanisms/social-behavior-neurodegeneration)
Background
The study of Vasopressin V1A Receptor Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
- [IUPHAR/BPS Guide to Pharmacology - V1a Receptor](https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=98) - Receptor pharmacology database
- [UniProt - AVPR1A (P37278)](https://www.uniprot.org/uniprot/P37278) - Protein structure and function
- [Allen Brain Atlas - AVPR1A Expression](https://mouse.brain-map.org/) - Gene expression visualization
- [OMIM - AVPR1A](https://www.omim.org/entry/192321) - Genetic associations
- [GeneCards - AVPR1A](https://www.genecards.org/cgi-bin/carddisp.pl?gene=AVPR1A) - Gene information
Overview
This section provides background information on the gene/protein and its role in the nervous system.
This overview section needs to be expanded with relevant scientific information from peer-reviewed sources.
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | cell-types-vasopressin-v1a-neurons |
| kg_node_id | None |
| entity_type | cell_type |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-7e8aabbcaa41 |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'cell-types-vasopressin-v1a-neurons'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-cell-types-vasopressin-v1a-neurons?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[vasopressin-v1a-neurons](http://scidex.ai/artifact/wiki-cell-types-vasopressin-v1a-neurons)
http://scidex.ai/artifact/wiki-cell-types-vasopressin-v1a-neurons